Anyone have any opinions on how self-insured employers consider innovative healthcare offerings to pass on to their employees?

As I understand it, by shouldering the financial risk, self-insured employers can curate a list of more relevant benefits ... (1/10)

... thereby avoiding paying out lofty insurance premiums for services that its employees don't use or want. There seems to be a long list of intangible benefits having to do with talent acquisition and retention, but I'd like to understand the cost equations more fully. (2/10)
In the context of multi-cancer screening, I'm skeptical that it could be cost-saving for small or medium-sized employers (<500 employees). Assuming a representative sample of the population, there are simply too few cancers and too many false positives w/ expensive ... (3/10)
... diagnostic follow-ups to bend the unit-economics in the right direction. Indeed, for larger self-insured employers, maybe on the order of thousands of employees, the dynamics may change. Each true positive is a chance to save on treatment cost and (possibly) to ... (4/10)
... extend life. However, employers won't likely be able to distinguish between true life-extension and lead-time bias without prospective, randomized studies, which are due out in the 2024-25 timeframe. Still, these likely will include interim endpoints only. (5/10)
Without public or private reimbursement, it may be challenging to prove the unit economics to early adopters, though this group is also the most likely to be cavalier in the absence of data, which brings me back to my original question cost and decision-making. (6/10)
With cancer screening, the negatives (and costs) are immediate, but the benefits may not manifest for years. I've considered how Accolade approaches the self-insured employer market, giving special attention to how it articulates the monetary benefits across relevant ... (7/10)
... time intervals in the wake of secularly-increasing healthcare premiums and a rising emphasis on out-of-pocket expenditures. I imagine screening companies moving this direction would have to articulate a similar value proposition to win over large contracts. (8/10)
Below is a link to the recent Aon <> Accolade study for reference.

I'm thinking about benchmarking to Accolade's average contract value for self-insured employers, as well as the savings it generates, to help dimension how cancer screening could diffuse into this market. (9/10)
Would welcome any input on how self-insured employers of various sizes would consider the tangible (cost) or intangible benefits/issues associated w/ multi-cancer screening as I keep building out the model.
https://t.co/dxP1YGp18t

More from Finance

I'm lucky to attain financial freedom before 30.

I credit Fintwit for my learnings.

Here's 10 key concepts every investor must know:

1. $$ needed to retire
2. Researching a business
3. Reading annual reports
4. Reading earnings calls
5. Criteria of a multi bagger

(Read on...)

6. Holding a multi bagger
7. Economic moats
8. When to buy a stock
9. Earnings vs cashflow
10. Traits of quality companies

Here's my 10 favourite threads on these concepts:

1. How much $$ do you need to retire

Before you start, you must know the end game.

To meet your retirement goals...

How much $$ do you need in your portfolio?

10-K Diver does a good job explaining what's a safe withdrawl rate.

Hint: It's NOT


2. Research a business

Your investment returns are a lagging indicator.

Instead, your research skills are the leading predictor of your results.

Conclusion?

To be a good investor, you must be a great business researcher.

Start with


3. Reading annual reports

This is the bread and butter of a good business analyst.

You cannot just listen to opinions from others.

You must learn to deep dive a business and make your own judgments.

Start with the 10k.

Ming Zhao explains it

You May Also Like

My top 10 tweets of the year

A thread 👇

https://t.co/xj4js6shhy


https://t.co/b81zoW6u1d


https://t.co/1147it02zs


https://t.co/A7XCU5fC2m